Dr. David SilverSenior Scientific Adviser
Dr. David Silver is well-known in the science community for his discovery of the MFSD2a-LPC pathway at the blood brain barrier. This discovery helped scientists understand how DHA is received by the brain and could eventually lead to new therapeutics for neurological diseases of the brain and eye.
Dr. Silver is a professor and deputy director of the Signature Research Program in Cardiovascular & Metabolic Disorders at Duke-NUS Medical School in Singapore. He has a research, focus on molecular nutrition and the role of lipids in brain and eye health.
Dr. Silver has a Ph.D. in Genetics from the University of Michigan. He conducted postdoctoral training in cardiovascular and lipid research at Columbia University. He also has tenure-track faculty appointments at Columbia and the Albert Einstein College of Medicine.